Patents by Inventor Geerten P. van Nieuw Amerongen

Geerten P. van Nieuw Amerongen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (ARG)
    Patent number: 9290765
    Abstract: The invention relates to the field of endothelial barrier dysfunction, particular, the invention relates to new methods for the treatment of endothelial barrier dysfunction, such as inflammatory edema by inhibiting Abl-related gene (ARG).
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: March 22, 2016
    Assignee: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG
    Inventors: Geerten P. van Nieuw Amerongen, Anton Vonk Noordegraaf, Jurjan Aman, Victor W. M. van Hinsbergh
  • PROTECTION AGAINST ENDOTHELIAL BARRIER DYSFUNCTION THROUGH INHIBITION OF THE TYROSINE KINASE ABL-RELATED GENE (ARG)
    Publication number: 20140187605
    Abstract: The invention relates to the field of endothelial barrier dysfunction, particular, the invention relates to new methods for the treatment of endothelial barrier dysfunction, such as inflammatory edema by inhibiting Abl-related gene (ARG).
    Type: Application
    Filed: May 2, 2011
    Publication date: July 3, 2014
    Applicant: VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG
    Inventors: Geerten P. van Nieuw Amerongen, Anton Vonk Noordegraaf, Jurjan Aman, Victor W. M. Hinsbergh